Intrapulmonary percussive ventilation (IPV) in acute exacerbations of chronic obstructive pulmonary disease (COPD) patients with mild respiratory acidosis: a randomised controlled trial

ISRCTN ISRCTN17802078
DOI https://doi.org/10.1186/ISRCTN17802078
Secondary identifying numbers N/A
Submission date
15/04/2005
Registration date
18/04/2005
Last edited
13/06/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Frederic Vargas
Scientific

Pellegrin-Tripode Hospital
Bordeaux
33076
France

Email frederic.vargas@chu-bordeaux.fr

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectivesWe hypothesised that the use of intrapulmonary percussive ventilation (IPV), a technique designed to improve mucus clearance, could prove effective in avoiding further deterioration in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) with mild respiratory acidosis.
Ethics approval(s)The experimental protocol was approved by the institutional review board of the hospital
Health condition(s) or problem(s) studiedAcute exacerbations of chronic obstructive pulmonary disease (COPD) patients with mild respiratory acidosis
InterventionComparison of two groups of COPD:
1. A standard goup: COPD patients with standard treatment alone
2. An IPV group: COPD patients with standard treatment plus IPV
Intervention typeOther
Primary outcome measureTherapy was considered to be successful when it enabled the avoidance of both a worsening of the exacerbation and a decrease in pH to under 7.35 (which would have required NIV), and allowed the patient to be discharged from the ICU.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2003
Completion date31/12/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants33
Key inclusion criteriaCOPD patients in acute excerbations and respiratory acidosis with pH between 7.35 and 7.38
Key exclusion criteria1. The requirement for emergency intubation for cardiopulmonary resuscitation, respiratory arrest, or in the case of rapid deterioration in neurological status (Glasgow coma scale inferior or equal to 8)
2. Hemodynamic instability defined as a systolic blood pressure of less than 80 mmHg or evidence on electrocardiography of ischemia or clinically significant ventricular arrhythmias
3. Failure of more than two additional organs; or tracheotomy, pneumothorax, facial deformity, or a recent history of oral, oesophageal or gastric surgery
Date of first enrolment01/01/2003
Date of final enrolment31/12/2004

Locations

Countries of recruitment

  • France

Study participating centre

Pellegrin-Tripode Hospital
Bordeaux
33076
France

Sponsor information

Pellegrin-Tripode Hospital (France)
Hospital/treatment centre

Place Amelie Rabat Leon
Bordeaux
33076
France

Email frederic.vargas@chu-bordeaux.fr
ROR logo "ROR" https://ror.org/02x581406

Funders

Funder type

Other

Not provided at time of registration

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/08/2005 Yes No